DCGI grants EUA to Omicron-specific mRNA-based booster vaccine
New Delhi: The Department of Biotechnology (DBT) has announced that the Omicron-specific mRNA-based Booster vaccine developed using the indigenous platform technology ...
New Delhi: The Department of Biotechnology (DBT) has announced that the Omicron-specific mRNA-based Booster vaccine developed using the indigenous platform technology ...
New Delhi: Zydus Cadila has received approval for Emergency Use Authorization (EUA) from the Drug Controller General of India (DCGI) ...
New Delhi: Bharat Biotech's intranasal vaccine is the first nasal vaccine that has received the regulatory approval for Phase 2 ...
New Delhi: Minister for Chemicals & Fertilizers D.V. Sadananda Gowda visited Bharat Biotech, Hyderabad on Sunday to oversee the Covaxin ...
Hyderabad: In a bid to augment the vaccine production, the Government has decided to support some public sector companies with ...